The Epic Sciences platform can identify and molecularly characterize circulating tumor cells in the blood to provide additional ways of assessing cancer and personalizing and monitoring treatments. Our laboratory has received certification under the Clinical Laboratory Improvement Amendments (CLIA). We can accept clinical samples for testing (CLIA ID: 05D2087488) and are certified for interventional clinical trials.

To discuss our current offerings, please contact us at

How is Epic Sciences working to improve patient outcomes? Learn about the the Epic Sciences advantage here.

Up to date with Epic Sciences

Contact us to request more information on our CLIA/CAP laboratory and testing capabilities.